Skip to main content

Update on Cancer Drug Nilotinib for Parkinson's Disease

August 2, 2016

In this webinar, clinicians, researchers and a patient share the current state of science and safety around the cancer drug nilotinib for the treatment of Parkinson's disease. Our panel also discuss plans for future testing.

Webinar Details


Tuesday, August 2, 2016


1 hr


12:00 pm ET
  • MJFF is not offering CME credit for this webinar. Visit webinars for our library of CME-accredited Third Thursdays webinars.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.